Proshares Trust (ZBIO) Cash & Current Investments (2023 - 2025)
Historic Cash & Current Investments for Zenas BioPharma (ZBIO) over the last 3 years, with Q3 2025 value amounting to $476.9 million.
- Zenas BioPharma's Cash & Current Investments rose 3243.08% to $476.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $476.9 million, marking a year-over-year increase of 3243.08%. This contributed to the annual value of $350.8 million for FY2024, which is 51692.67% up from last year.
- Per Zenas BioPharma's latest filing, its Cash & Current Investments stood at $476.9 million for Q3 2025, which was up 3243.08% from $504.2 million recorded in Q2 2025.
- Zenas BioPharma's 5-year Cash & Current Investments high stood at $504.2 million for Q2 2025, and its period low was $37.2 million during Q1 2024.
- For the 3-year period, Zenas BioPharma's Cash & Current Investments averaged around $274.7 million, with its median value being $350.8 million (2024).
- Data for Zenas BioPharma's Cash & Current Investments shows a peak YoY increase of 105473.95% (in 2025) and a maximum YoY decrease of 3243.08% (in 2025) over the last 5 years.
- Zenas BioPharma's Cash & Current Investments (Quarter) stood at $56.9 million in 2023, then soared by 516.93% to $350.8 million in 2024, then skyrocketed by 35.97% to $476.9 million in 2025.
- Its last three reported values are $476.9 million in Q3 2025, $504.2 million for Q2 2025, and $430.0 million during Q1 2025.